Rejected at 7:04 p.m. Oct, 31, 2023 ] by Alex
Author: jpk429
Related Note: 1489963536616
Rationale for change

Clarification on receptor selectivity

Rejection reason

sitting for over a month, another suggestion resolves this partially

Extra Extra
Text
Terazosin is a(n) {{c1::selective α1}} receptor antagonist used to treat benign prostatic hyperplasia (BPH) in patients with {{c2::hypertension}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Reproduction::05_Male_Pathology::08_Benign_Prostatic_Hyperplasia #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::02_Hypertension_Management #PANCE::EOR::Family_med #AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::14_Tamsulosin #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::14_alpha-blockers::*Selective_a1_Antagonists::Terazosin #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::03_Alpha_drugs #AK_Step1_v12::#FirstAid::15_Repro::04_Pathology::42_Benign_prostatic_hyperplasia::*Treatment #AK_Step1_v12::^Systems::Reproductive::Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::15_Alpha_Adrenergic_Antagonists #AK_Step1_v12::#AMBOSS::qMaCpO #AK_Step1_v12::#Pathoma::14_Male::04_Prostate #AK_Step1_v12::#SketchyPharm::Reproductive #PANCE::GU::benign_prostatic_hyperplasia #AK_Step1_v12::#AMBOSS::JXas_Q #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::03_osin_Drugs #AK_Step1_v12::#OME_banner #AK_Step1_v12::#AMBOSS::11a2fj !AK_UpdateTags::Step1decks::Zanki-Pharmacology